Decompensated Heart Failure Clinical Trial
Official title:
Impact of Therapy Optimization on the Level of Biomarkers in Patients With Acute Decompensated and Decompensated Chronic Heart Failure
In this pilot, investigator-initiated multi-centre, multinational, observational study the
investigators would like to examine the impact of therapy optimization on the level of
biomarkers in patients with acute decompensated and decompensated chronic heart failure.
The primary objective is to determine the best time point for measuring biomarker levels
during therapy optimization in patients with decompensation to predict clinical outcomes such
as mortality, hospitalisation, and quality of life.
Secondary objectives are:
1. To evaluate the impact of guideline-recommended medication on biomarker levels during
and following recompensation.
2. To evaluate whether the trajectory of relevant biomarkers (MR-proANP, MR-proADM) is of
relevance to guide medical therapy following decompensation.
3. To evaluate whether the degree of biomarker change (e.g. slow versus rapid change) is of
relevance with regard to hemodynamic stability and cardiovascular events such as
hospitalisation.
4. To evaluate whether the trajectory of relevant biomarkers (copeptin, CT-pro-ET1) is of
relevance to guide medical therapy following decompensation.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT05910437 -
Optimizing Treatments for Heart Failure During Hospitalization
|
||
Terminated |
NCT00355017 -
BNP Guided Care in Addition to Multidisciplinary Care
|
N/A | |
Active, not recruiting |
NCT03701880 -
Early Use of Ivabradine in Heart Failure
|
N/A | |
Recruiting |
NCT03157219 -
Manipal Heart Failure Registry (MHFR)
|
N/A | |
Recruiting |
NCT06114498 -
Hospital Register of Decompensated Heart Failure With Preserved Ejection Fraction
|
||
Completed |
NCT03838003 -
Exercise in Patients Admitted With Recently Decompensated Heart Failure
|
N/A | |
Completed |
NCT02997462 -
Monocyte Phenotypic Changes in Heart Failure
|
||
Completed |
NCT04493346 -
Shear Wave Elastography
|
||
Recruiting |
NCT02666651 -
Regional Tolvaptan Registry
|
Phase 4 | |
Recruiting |
NCT02236247 -
Control of Sinus Node Tachycardia as an Additional Therapy in Patients With Decompensated Heart Failure
|
Phase 1/Phase 2 | |
Not yet recruiting |
NCT06273397 -
Acetazolamide or Metolazone in Acute Heart Failure
|
N/A | |
Completed |
NCT05927285 -
Effect on Kidney Function Recovery Guiding Decongestion With VExUS in Patients With Cardiorenal Syndrome 1
|
N/A | |
Withdrawn |
NCT04572867 -
Aquapheresis Efficacy in Outpatients With Decompensated Heart Failure
|
N/A | |
Completed |
NCT02157506 -
A Dose Ranging Phase IIa Study of 6 Hour Intravenous Dosages of CXL-1427 in Patients Hospitalized With Heart Failure
|
Phase 2 | |
Recruiting |
NCT03914222 -
Comparing PA Compliance During and After Decompensation in HFP
|
N/A | |
Recruiting |
NCT06286423 -
Colchicine in Acutely Decompensated HFREF
|
Phase 4 | |
Recruiting |
NCT03009552 -
Speckle Tracking Echocardiography Adds Information in Decompensated Heart Failure
|
N/A | |
Completed |
NCT04019314 -
Assessment of ProEnkephalin to Detect Acute Kidney Injury (AKI)
|
N/A | |
Recruiting |
NCT02649517 -
Clinical and Morphological Characteristics of Chronic Inflammation in the Myocardium in Patients With Decompensated HF With Ischemic Systolic Dysfunction
|
N/A | |
Recruiting |
NCT03440970 -
Mechanism and Effects of Manipulating Chloride Homeostasis in Stable Heart Failure
|
Early Phase 1 |